118 related articles for article (PubMed ID: 1557832)
21. Diagnostic value of microvillus-matrix associations in tumors.
Ghadially FN; McCaughey WT; Perkins DG; Rippstein P
J Submicrosc Cytol Pathol; 1992 Jan; 24(1):103-8. PubMed ID: 1617606
[TBL] [Abstract][Full Text] [Related]
22. Ultrastructure of metastatic rete testis adenocarcinoma.
Mrak RE; Husain MM; Schaefer RF
Arch Pathol Lab Med; 1990 Jan; 114(1):84-8. PubMed ID: 2294871
[TBL] [Abstract][Full Text] [Related]
23. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas.
Mizutani Y; Nakajima T; Morinaga S; Gotoh M; Shimosato Y; Akino T; Suzuki A
Cancer; 1988 Feb; 61(3):532-7. PubMed ID: 3338020
[TBL] [Abstract][Full Text] [Related]
25. [A case of metastatic pulmonary cancer from urachal carcinoma that required differentiation from primary lung adenocarcinoma].
Tatsuno M; Tamura S; Taniguchi F; Yasuoka H; Nasu H; Fujimoto T
Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):848-54. PubMed ID: 22171490
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic difficulties in diffuse pulmonary infiltrations].
Zielińska-Leś I; Kamiński J; Kozielski J
Wiad Lek; 2006; 59(9-10):724-6. PubMed ID: 17338139
[TBL] [Abstract][Full Text] [Related]
27. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
28. Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration.
Min KW
Ultrastruct Pathol; 2013 Feb; 37(1):23-35. PubMed ID: 23383615
[TBL] [Abstract][Full Text] [Related]
29. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
30. Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management.
Remo A; Zanella C; Pancione M; Astati L; Piacentini P; Cingarlini S; Bonetti A; Micheletto C; Talamini A; Chilosi M; Vendraminelli R; Manfrin E
Pathologica; 2013 Apr; 105(2):69-72. PubMed ID: 23946985
[TBL] [Abstract][Full Text] [Related]
31. "Thick" cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma.
Leong AS; Parkinson R; Milios J
Diagn Cytopathol; 1990; 6(1):9-13. PubMed ID: 2323301
[TBL] [Abstract][Full Text] [Related]
32. Gynaecological or gastrointestinal origin? Recognising Müllerian neoplasms with gastrointestinal phenotype and determining the primary site in selected entities.
Ronquillo N; Pinto A
Pathology; 2022 Mar; 54(2):207-216. PubMed ID: 34844746
[TBL] [Abstract][Full Text] [Related]
33. An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast.
Warhol MJ; Corson JM
Hum Pathol; 1985 Jan; 16(1):50-5. PubMed ID: 2982715
[TBL] [Abstract][Full Text] [Related]
34. The biological implications of bronchial tumors.
Warren WH; Memoli VA; Kittle CF; Jensik RJ; Faber LP; Gould VE
J Thorac Cardiovasc Surg; 1984 Feb; 87(2):274-82. PubMed ID: 6319828
[TBL] [Abstract][Full Text] [Related]
35. Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
Jassim SH; Khiyami A; Nguyen JK; Ganesan S; Tomashefski J; Sawady J
J Med Case Rep; 2017 May; 11(1):133. PubMed ID: 28494807
[TBL] [Abstract][Full Text] [Related]
36. Giant cell carcinoma of the lung--immunohistochemical and ultrastructural evidence of dedifferentiation.
Addis BJ; Dewar A; Thurlow NP
J Pathol; 1988 Jul; 155(3):231-40. PubMed ID: 2457672
[TBL] [Abstract][Full Text] [Related]
37. Metastatic biphasic pulmonary adenocarcinoma mimicking malignant gastrointestinal stromal tumour.
Allen DC; Davis RI
Ulster Med J; 1995 Oct; 64(2):181-4. PubMed ID: 8533186
[No Abstract] [Full Text] [Related]
38. Colon carcinoma metastatic to the lung. Cytologic manifestations and distinction from primary pulmonary adenocarcinoma.
Flint A; Lloyd RV
Acta Cytol; 1992; 36(2):230-5. PubMed ID: 1543007
[TBL] [Abstract][Full Text] [Related]
39. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Suzuki A; Shijubo N; Yamada G; Ichimiya S; Satoh M; Abe S; Sato N
Pathol Res Pract; 2005; 201(8-9):579-86. PubMed ID: 16259111
[TBL] [Abstract][Full Text] [Related]
40. Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.
Toda-Ishii M; Akaike K; Kurisaki-Arakawa A; Arakawa A; Mukaihara K; Suehara Y; Takagi T; Kaneko K; Yao T; Saito T
Int J Clin Exp Pathol; 2015; 8(3):3270-8. PubMed ID: 26045851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
